Company Filing History:
1 out of 63 
1 out of 26 Years Active: 2016
Title: David Michael Adrien Taddei: Innovator in Pharmaceutical Chemistry
Introduction
David Michael Adrien Taddei is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work has led to the creation of a patent that addresses important medical challenges.
Latest Patents
David holds a patent for "Pyrazole derivatives as p38 MAP inhibitors," which includes compounds of formula (I). This invention represents a crucial advancement in the search for effective treatments targeting specific pathways in disease processes. His patent is a testament to his expertise and dedication to improving healthcare through innovative solutions.
Career Highlights
Throughout his career, David has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Respivert Limited and Topivert Pharma Limited. His experience in these organizations has allowed him to contribute to various projects aimed at developing new therapeutic options.
Collaborations
David has collaborated with talented professionals in his field, including Lorna Duffy and John King-Underwood. These partnerships have enriched his work and fostered an environment of innovation and creativity.
Conclusion
David Michael Adrien Taddei is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in medical treatments. His patent and collaborations reflect his commitment to innovation and improving patient outcomes.